Author

A. Tiefenbacher

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:biophysical modeling· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:clustering· 1

Frequent Co-Authors

G. Egger· 2 shared G. Schweikert· 2 shared B. H. Ramsahoye· 1 shared B. Neudert· 1 shared B. Tichy· 1 shared C. Binder· 1 shared C. Bock· 1 shared C. d. J. Cardona· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

G. Egger

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mimicking tumor cell heterogeneity of colorectal cancer in a patient-derived organoid-fibroblast model

V. S. Atanasova, C. d. J. Cardona, V. Hejret, A. Tiefenbacher, L. Tran, C. Binder, T. Mair, J. Kabiljo, J. Clement, K. Woeran, B. Neudert, M. Hengstschlaeger, M. Mitterhauser, L. Muellauer, B. Tichy, , G. Egger

This paper develops a colorectal cancer organoid model incorporating patient-derived fibroblasts, showing enhanced cellular heterogeneity and morphology compared to mono-cultures.

bioRxiv · Mar 7, 2022Cancer Biology

Requirement of DNMT1 to orchestrate epigenomic reprogramming during NPM-ALK driven T cell lymphomagenesis

E. Redl, R. Sheibani-Tezerji, P. Hamminger, G. Timelthaler, M. R. Hassler, S. Lagger, T. Dillinger, L. Hofbauer, M. Zrimsek, A. Tiefenbacher, M. Kothmayer, C. H. Dietz, B. H. Ramsahoye, L. Kenner, C. Bock, , G. Egger

This study shows that DNMT1 is essential for maintaining tumor-specific methylation during NPM-ALK driven T cell lymphomagenesis, despite oncogenic signaling.

bioRxiv · Apr 9, 2020 · PreprintCancer Biology